ICICI Direct: Aarti Industries’ Beat On Revenues; Miss On Margins In Q2

ICICI Direct: Aarti Industries’ Beat On Revenues; Miss On Margins In Q2

A researcher performs tests inside a co-lab in Singapore.(Photographer: Nicky Loh/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Aarti Industries Ltd.’s Q2 FY21 gross revenues grew 23.5% YoY to Rs 1330.4 crore amid strong growth in both segments.

Specialty chemical revenues grew 23.9% YoY to Rs 1108.8 crore. Pharma revenues grew 21.7% YoY to Rs 221.6 crore.

However, owing to higher goods and services tax outgo, operational revenues grew 8.9% YoY to Rs 1172.6 crore.

Ebitda margins fell 191 basis points YoY to 21.7% amid higher fixed cost and adverse product mix in chemical segment.

Click on the attachment to read the full report:

ICICI Direct Aarti Industries Q2FY21 Result Update.pdf
Read Document

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story
Subscribe to unlock & enjoy all
Members-only benefits
Still Not convinced ?  Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
GET REGULAR UPDATES